Pfizer forecast 2025 revenue and earnings in line with market expectations, despite a $1 billion hit from the redesign of federal drug benefits.
Related Posts
Volvo Car Cuts Guidance on Worsening Auto Market
The Swedish car maker cut its full-year guidance and said it now anticipates negative cash flow due to lower sales expectations and a weak market.
Victoria’s Secret CEO Exits; Savage X Fenty’s Hillary Super Named Successor
Super’s appointment is effective Sept. 9, and CFO Timothy Johnson will serve as interim CEO until then.
FTC Blocks Tempur Sealy, Mattress Firm’s Deal on Competition Concerns
The regulator alleges the acquisition of Mattress Firm would provide Tempur Sealy with the ability and incentive to suppress competition and raise prices for mattresses […]